Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2019

01-05-2019 | Original Article

YouTube as a source of information in retinopathy of prematurity

Authors: Alparslan Şahin, Muhammed Şahin, Fatih Mehmet Türkcü

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2019

Login to get access

Abstract

Aim

We aimed to evaluate the quality of information available on YouTube regarding the basic information, examination, diagnosis, and the treatment of retinopathy of prematurity (ROP).

Methods

A YouTube search was performed on https://​www.​youtube.​com/ for videos pertaining to “retinopathy of prematurity” and “ROP.” The first 100 relevant videos were included in the study. Two ophthalmologist reviewers independently evaluated and classified the videos as useful or misleading. The videos were accepted as “useful,” if they provide scientifically correct information about any aspect of ROP: cause, pathogenesis, symptoms, findings, treatments, procedure details of the treatment, epidemiology, and prognosis. The videos contain scientifically unproven information are defined as “misleading.” Videos were also classified according to the source: surgeon/practitioner, independent user, hospital/free clinic, social media/TV, medical site, university, and advertisement.

Results

The mean duration, the mean days on YouTube, the mean comments per videos, and the mean dislikes per video were similar in useful and misleading videos. However, the mean likes per day, mean view per video, and mean view per day were significantly higher in useful videos than those of misleading videos (p = 0.004, p = 0.022, and p = 0.011, respectively). Most of the useful videos were uploaded by healthcare professionals including source from university, hospital/free clinic, and surgeon/practitioner (48/64). The videos uploaded by healthcare professionals were more useful compared to those of non-healthcare professionals (p = 0.029).

Conclusion

YouTube could be used as an important tool for patient information in ROP. However, one third of the YouTube videos regarding ROP are misleading and may present a risk of harmful consequences. In this aspect, authoritative videos by healthcare professionals should be uploaded for dissemination of reliable information on ROP.
Literature
1.
go back to reference Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A, International NO-ROP Group (2005) Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 115:e518–e525. https://doi.org/10.1542/peds.2004-1180 CrossRefPubMed Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A, International NO-ROP Group (2005) Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 115:e518–e525. https://​doi.​org/​10.​1542/​peds.​2004-1180 CrossRefPubMed
5.
go back to reference Madden A, Ruthven I, McMenemy D (2013) A classification scheme for content analyses of YouTube video comments. J Doc 69:693–714CrossRef Madden A, Ruthven I, McMenemy D (2013) A classification scheme for content analyses of YouTube video comments. J Doc 69:693–714CrossRef
Metadata
Title
YouTube as a source of information in retinopathy of prematurity
Authors
Alparslan Şahin
Muhammed Şahin
Fatih Mehmet Türkcü
Publication date
01-05-2019
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2019
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1902-2

Other articles of this Issue 2/2019

Irish Journal of Medical Science (1971 -) 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.